Are you Dr. Kantor?
Join over one million U.S. Physicians, Nurse Practitioners and PAs, already on Doximity.
- Connect with colleagues in the same hospital or clinic
You already have 41 invites waiting! - Search all U.S. specialist profiles and refer a patient
- Read the latest clinical news and earn CME/CEU credits
Office
3400 Spruce St
Philadelphia, PA 19104Phone+1 215-662-2737- Is this information wrong?
Summary
- Dr. Jonathan Kantor, MD is a board certified dermatologist in Philadelphia, Pennsylvania. He is currently licensed to practice medicine in Pennsylvania, Georgia, and Massachusetts.
Education & Training
University of Pennsylvania Health SystemResidency, Dermatology, 2002 - 2005- University of Pennsylvania Health SystemInternship, Internal Medicine, 2001 - 2002
Perelman School of Medicine at the University of PennsylvaniaClass of 2001
Certifications & Licensure
FL State Medical License 2004 - 2025
PA State Medical License 2001 - 2024
MA State Medical License 2017 - 2022
GA State Medical License 2017 - 2020- American Board of Dermatology Dermatology
Awards, Honors, & Recognition
- CMS Meaningful Use Stage 1 Certification EpicCare Ambulatory EMR, Epic Systems Corporation, 2012-2013
- Fellow (FAAD) American Academy of Dermatology
Publications & Presentations
PubMed
- This Month in JAAD International: June 2024: Acne and quality of life.Jonathan Kantor> ;Journal of the American Academy of Dermatology. 2024 Apr 2
- 2 citationsBest practices for implementing ChatGPT, large language models, and artificial intelligence in qualitative and survey-based research.Kantor, J.> ;JAAD International. 2024 Mar 1
- This Month in JAAD International: May 2024: Randomized controlled trials, within-patient controls, and end points.Jonathan Kantor> ;Journal of the American Academy of Dermatology. 2024 May 1
- Join now to see all
Press Mentions
Epidemiologist Says It’s ‘Extremely Challenging’ to Paint a Full Picture of COVID-19 CasesDecember 5th, 2022- Duval & Other Neighboring Counties Still Considered ‘High’ COVID Community Level: CDCFebruary 25th, 2022
- FDA Postpones Meeting on Pfizer Vaccine for Young ChildrenFebruary 11th, 2022
- Join now to see all
Professional Memberships
- Fellow
